$OKUR

$2.60 +$0.12 (4.85%) Close

$OKUR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 40.5M shares outstanding

Who owns OKUR?

By type of holder

Institutions 86.1% Insiders 13.9% Everyone else 0.0%

Concentration Top 10 holders own 129.2%

AI Biotechnology LLC 22.5% · Access Industries Holdings LLC 22.5%

Institutional ownership

86.1%

+18.1 pts vs last qtr

Institutional holders

+24 vs last qtr

Net shares bought

+7.3M

by institutions in Q2 2026

New / sold out

32 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +1.5M
Trails Edge Capital Partners, LP NEW +1.4M

Biggest sellers in Q2 2026

Foresite Capital Management VI LLC SOLD OUT −1.4M
Prosight Management, LP −1.2M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Onkure Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+566.4%

+46.13% a year

Each share's claim on the business

−85.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$4.4M vs $25M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years14% 3–5 years6% 1–3 years25% Under 1 year55%

Quarterly turnover

26.6%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting OKUR on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Ra Capital Management, L.P.	4.0M	9.87%	Unchanged	Q1 '26	0.2%
Shares held by quarter Peak holding4.0M (Q1'26) Change over 8 quarters+4.0M Share of the company9.870% Ra Capital Management, L.P.'s full portfolio →
BI BVF Inc/il	3.2M	7.99%	+1.3M (+63.5%)	Q1 '26	0.4%
Shares held by quarter Peak holding3.2M (Q2'26) Change over 8 quarters+3.2M Share of the company7.990% BVF Inc/il's full portfolio →

Ra Capital Management, L.P.

4.0M

% of company

9.87%

Change vs last qtr

Unchanged

Held since

Q1 '26

BVF Inc/il

3.2M

% of company

7.99%

Change vs last qtr

+1.3M (+63.5%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Onkure Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting OKUR on Form N-PORT; together they hold 7.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$5.06M	1.1M	2.74%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$2.2M	483.1K	1.19%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$5.06M

% of company

2.74%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$2.2M

% of company

1.19%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Onkure Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AB AI Biotechnology LLC 5%+ holder 13D · 20.0%	9.1M	22.45%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company22.450% Disclosed stake13D · 20.0% View the 13D/G filing →
AI Access Industries Holdings LLC 5%+ holder 13D · 20.0%	9.1M	22.45%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company22.450% Disclosed stake13D · 20.0% View the 13D/G filing →

AI Biotechnology LLC

5%+ holder13D · 20.0%

9.1M

% of company

22.45%

Change vs last qtr

—

Held since

—

Access Industries Holdings LLC

5%+ holder13D · 20.0%

9.1M

% of company

22.45%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Onkure Therapeutics Inc.

Comments